News
Minority correctly use EpiPen or metered dose inhaler
- Author:
- Sherry Boschert
Major finding: Twelve percent of patients showed they could use an EpiPen correctly, and 7% knew how to use a metered dose inhaler and spacer.Data...
News
Sacral nerve stimulation reduced irritable bowel symptoms
- Author:
- Sherry Boschert
Major finding: Median symptom scores worsened by 12 points between months when the stimulator was on and then off and improved by 18 points...
News
Asthma medication nonadherence mainly unintentional
- Author:
- Sherry Boschert
Major finding: Adults and children were more likely to report unintentional than intentional nonadherence to asthma therapy. Data source:...
News
VIDEO: Study highlights progress, challenges in nosocomial infections
- Author:
- Sherry Boschert
News
Systolic variability after intracerebral hemorrhage raises odds of death, disability
- Author:
- Sherry Boschert
Major finding: Death or major disability were 41% more likely in patients in the highest quintile of systolic variability 1 day after acute...
News
Recent cocaine use quadrupled stroke risk
- Author:
- Sherry Boschert
Major finding: Cocaine use in the past 24 hours was reported by 2.4% of young adults with ischemic stroke and 0.4% of age-matched controls without...
News
Half of stroke survivors returned to driving
- Author:
- Sherry Boschert
Major finding: Six percent of stroke survivors underwent formal driving evaluations, but 51% of survivors returned to driving within 1 year.Data...
News
Foods can trigger EoE after allergy is outgrown
- Author:
- Sherry Boschert
Major finding: Seventeen of 425 children with eosinophilic esophagitis caused by a specific food redeveloped the condition after outgrowing an...
News
Biomarker unreliability scratches trial of customized chemotherapy
- Author:
- Sherry Boschert
Major finding: Eighty percent of patients had biomarker status results and could start adjuvant chemotherapy within 2 months of surgery, but test...
News
Amrubicin combination fails in phase III trial
- Author:
- Sherry Boschert
Major finding: Median overall survival was 15 months using amrubicin/cisplatin, significantly worse than 17.7 months using irinotecan/cisplatin....
News
Palliative care shortens ICU, hospital stays, review shows
- Author:
- Sherry Boschert
News
Relatively few in ICUs get end-of-life dialogue training
- Author:
- Sherry Boschert
Major finding: Half of doctors and 29% of nurses in ICUs said they had received formal training in end-of-life communications.Data source: A...
News
Two definitions of Gulf War illness recommended
- Author:
- Sherry Boschert
News
VIDEO: Eosinophilic esophagitis may follow outgrown food allergy
- Author:
- Sherry Boschert
News
List of allergy care ‘don’ts’ expanded
- Author:
- Sherry Boschert